Albert L. Reese Jr. - 18 May 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Albert Reese Jr./
Issuer symbol
LEXX
Transactions as of
18 May 2022
Net transactions value
+$6,431
Form type
4
Filing time
19 May 2022, 16:47:01 UTC
Previous filing
08 Mar 2022
Next filing
24 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX common shares Award $3,414 +1,700 +185% $2.01 2,617 18 May 2022 Direct
transaction LEXX common shares Award $3,017 +1,501 +57% $2.01 4,118 19 May 2022 Direct
holding LEXX common shares 917 18 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 3,400 18 May 2022 Common Shares 3,400 $4.80 Direct
holding LEXX Stock Options 6,800 18 May 2022 Common Shares 3,400 $3.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.